World News

Chemotherapy-Free Triplet 'Sets a New Benchmark' in Follicular Lymphoma

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c

Chemotherapy-Free Triplet 'Sets a New Benchmark' in Follicular Lymphoma (MedPage Today) — ORLANDO — Adding the bispecific antibody epcoritamab (Epkinly) to a standard chemotherapy-free regimen for relapsed or refractory follicular lymphoma improved responses and reduced the risk of disease progression or death…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button